Minerva Neurosciences, Inc. (NERV)
NASDAQ·Healthcare·Biotechnology
$4.56
-1.41%
Mkt Cap $55.94M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+9.8%
Consensus $5.00 vs current $4.56
NASDAQ·Healthcare·Biotechnology
$4.56
-1.41%
Mkt Cap $55.94M
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
+9.8%
Consensus $5.00 vs current $4.56